Therapeutics I Exam III (Anti-Coagulation) Flashcards

Anti-Coagulation

1
Q

What is the brand name for Apixaban?

A

Eliquis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the brand name for Colpidogrel?

A

Plavix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the brand name for Enoxaparin?

A

Lovenox

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the brand name for Rivaroxaban?

A

Xarelto

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the brand name for Warfarin?

A

Coumadin and Jantoven

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is normal body temperature?

A

98.6F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the normal respiratory rate?

A

12-18 breaths per minute

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does a basic metabolic panel evaulate?

A

Kidney function, blood acid/base balance, blood sugar, and electrolytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the normal range for blood urea nitrogen (BUN)?

A

8-20 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the normal range for carbon dioxide?

A

24-31 mEq/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the normal range for Creatinine (SCr)?

A

0.6-1.2 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the normal range for glucose?

A

Less than 100 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the normal range for chloride?

A

95-105 mEq/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the normal range for serum potassium?

A

3.5-5 mEq/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the normal range for serum sodium?

A

135-145 mEq/L

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the normal range for serum calcium?

A

8.5-10.2 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Typically when calculating creatinine clearance, ideal body is used. What is used instead when calculating creatinine clearance for patients with obesity?

A

Use adjusted body weight

ABW= IBW +0.4(ABW-IBW)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What does a complete blood count (CBC) evaluate?

A

It tells information about cell counts in the blood. It is vital in monitoring anticoagulants and antiplatelets.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What do coagulation studies like prothrombin time (PT), International Normalized Ratio (INR), and aPTT tell us?

A

It measures how quickly the blood clots and it used to monitor anticoagulants.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What is the normal range for prothrombin time (PT)?

A

8.4-12.3 Seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the normal range for International Normalized Ratio (INR)?

A

0.8-1.2 for those not on any anticoagualtion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What is the normal range for activated/adjusted partial thromboplastin time (aPTT)?

A

25-36 seconds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is the meaning of hemostasis?

A

To stop bleeding. This is the goal out body has when we start bleeding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

The extrinsic pathway in the coagulation cascade is triggered by _____________ injury.

A

Endothelial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Tissue factor triggers coagulation once activated. It generates a small amount of _____________ and requires ___________ for the pathway to work.

A

Thrombin
Protein Disulfide Isomerase (PDI)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Tissue factor along with factor VIIa activate 3 substrates. What are those 3 substrates?

A

Obviously activates VII to VIIa
Activates IX to IXa
Activates X to Xa (inefficent)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

When factor Xa and V bind to each other at the beginning of the common pathway, what is that complex called?

A

Prothrombinase complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Thrombin converts fibrinogen to _________.

A

Fibrin (Ia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Once hemostasis is reached after all the clotting cascades, tissue factor is _____________.

A

Inactivated and fibrin clot degrades through fibrinolysis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

What are the 4 main intrinsic anticoagulants that they body produces?

A
  1. Nitric oxide and Prostacyclin (inhibit platelet aggregation)
  2. Antithrombin (inhibits all coagulation cascades)
  3. Proteins C and S (degrade factor Va and VIIIa)
  4. Tissue factor pathway inhibitor (TFPI) ( inhibit factors Xa and VIIa)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

The intrinsic anticoagulants nitric oxide and prostacyclin work by inhibiting __________ _____________.

A

Platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

The intrinsic anticoagulant antithrombin works by inhibiting __________ pathways.

A

Coagulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

The intrinsic anticoagulants protein C and S work by degrading factors ______ and ______.

A

Va and VIIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

The intrinsic anticoagulant tissue factor pathway inhibitor (TFPI) works by binding and inhibiting factors ______ and ______.

A

Xa and VIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

What is really the only vitamin K antagonist medication that is still used today?

A

Warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Vitamin K antagonist like warfarin inhibit factors _______, ______, _____, and _______, as well as proteins C and S synthesized in the liver.

A

II, VII, IX, and X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

What is the MOA of vitamin K antagonists?

A

They inhibit vitamin K epoxide reductase which limits the production of factors II, VII, IX, and X as well as protein C and S made from the liver.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

T or F: Vitamin K antagonists like Warfarin are not prodrugs.

A

False. This class of medications requires carboxylation to become active.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

T or F: Warfarin can decrease clotting factors by 30-70%.

A

True! The actual amount varies from person to person.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

How does vitamin K play a role in the coagulation cascade?

A

Vitamin K is crucial in the creating and activating clotting factors present in the coagulation cascade. Vitamin K antagonist inhibit the enzyme the recycles the oxidized vitamin K into reduced vitamin K so it no longer works in creating clotting factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

T or F: Warfarin inhibits the oxidation of vitamin K.

A

True. It blocks VKOR from oxidizing vitamin K to stop its activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Warfarin is 99% _______ bound.

A

Protein bound. This means a person with low albumin per say will have more free drug in their body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

There are two stereoisomers for Warfarin (R,S)? Via which enzymes are each of the stereoisomers metabolized by?

A

R-warfarin is metabolized by CYP1A1, 1A2, and 3A4 while S-warfarin is metabolized by CYP2C9.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Warfarin is unique in the fact that dosing is based on _________ and not days.

A

Weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

The half-life of warfarin is around 25-60 hours depending on genomics. The duration of the drug is around ____-_____ days.

A

2-5 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

T or F: Warfarin has a wide therapeutic index.

A

False! Warfarin has a very narrow therapeutic index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

What determines the onset of action of vitamin K antagonists like Warfarin?

A

Onset of action is determined by the half life of the already present clotting factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Which clotting factor has the longest half-life?

A

Factor II (60 hours)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

What is bridging?

A

This is a term used to describe the administration of Heparin or Enoxaparin after Warfarin administration in order to decrease the risk for clotting at the initiation of warfarin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

T or F: Right at initiation of Warfarin, the risk for clotting actually increases due to the long half-lifes of the clotting factors it inhibits.

A

True!! That is why bridging is done with IV anticoagulants to decrease the risk for initial clotting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

T or F: Warfarin is always given with a loading dose to get patients to therapeutic levels quicker.

A

False! Loading doses with Warfarin were only shown to decrease factor VII faster but not the others and it increases the risk for bleeding. Loading doses for Warfarin are typically not recommended.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

T or F: INR is a standardized value that can be comparatively used to determine a patient’s adherence and response to Warfarin or other anticoagulants.

A

True!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

A prothrombin time of _______ (INR 3.7-4) increases the risk for bleeding.

A

Two. A PT of over 2 is not wanted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
54
Q

The odds of a subdural hemorrhage increase ________x as prothrombin time increases from 2 to 2.5.

A

7.6x

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
55
Q

Based on clinical trials, the ideal INR for someone on Warfarin therapy is between ____-_____ with changes based on the condition.

A

2-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
56
Q

What is the INR goal someone with a venous thromboembolism?

A

2-3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
57
Q

What is the INR goal for someone with a mechanical heart valve?

A

2.5-3.5
We go higher on this as those with these types of valves readily clot.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
58
Q

T or F: While on Warfarin therapy, patients need to consume the same amount of vitamin K per day.

A

False. Patients need to consume the same amount of vitamin K per week, not per day.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
59
Q

Increased vitamin K levels in the body lead to a __________ INR.

A

Decreased.

This makes sense as vitamin K aids in clotting so too much of it will overpower Warfarin anatongist properties and cause INR to decrease and therefore increase risk of a clot.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
60
Q

What is the typical dosing for Warfarin (Coumadin)?

A

5 mg PO per day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
61
Q

What are the factors that can influence sensitivity to warfarin?

A

75 and older, clinical congestive HF, Diarrhea, drug interactions, elevated baseline INR, fever (acute illnesses), hyperthyroidism, cancer (prothrombotic state), malnutrition, and CYP2C9 and VCOR polymorphisms.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
62
Q

What are the 6 main contraindications for Warfarin use?

A
  1. PREGNANCY
  2. Risk of hemorrhage
  3. Senility, alcoholism, psychosis (general lack of patient safety and ability to adhere to Warfarin therapy)
  4. Spinal puncture procedures with potential for bleeding
  5. Inability to go to lab for INR
  6. Frequent falls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
63
Q

What are the main side effects of warfarin?

A

Bleeding and necrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
64
Q

What is the black box warning for warfarin?

A

Bleeding risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
65
Q

What is the antidote to warfarin?

A

Vitamin K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
66
Q

What are some risk factors that increase the risk for major bleeding?

A

Intense anticoagulation therapy, initiation of therapy, unstable INR, 65 and older, concurrent antiplatelet therapy, concurrent NSAID use, history of GI bleeds, recent surgery or trauma, high risk for falls, heavy alcohol use, renal failure, cerebrovascular disease, and cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
67
Q

What is the dosing for vitamin K when used as the antidote for warfarin?

A

1-10mg orally (preferred) or IV.

Oral is preferred as the liver synthesizes clotting factors and with oral 1st pass metabolism, it places vitamin K at the site of action to induce clotting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
68
Q

A person has INR between 4.5-10 with no bleeding. Should they be treated with vitamin K therapy?

A

No.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
69
Q

A person has INR above 10 but with no bleeding. Should they be treated with vitamin K therapy?

A

Oral vitamin K should be administered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
70
Q

A person presents with major bleeding. What should be done?

A
  • Rapid reversal of anticoagulation with four-factor PCC rather than plasma
  • Use vitamin K, 5-10mg, via slow IV injection rather than coagulation factors alone
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
71
Q

Febrile illness with warfarin therapy can increase INR via what mechanism?

A

Febrile illness can increase INR via increased catabolism of clotting factors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
72
Q

Acute ethanol ingestion, liver disease, and/or heart failure with warfarin therapy can increase INR via what mechanism?

A

Inhibition of warfarin metabolism and diminished production of clotting factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
73
Q

Malnutrition, lots of vomiting/diarrhea, and/or chemo-induced mucositis/stomatitis with warfarin therapy can increase INR via what mechanism?

A

Increased warfarin sensitivity due to decrease vitamin K intake and production and increased vitamin K removal from GIT. Low albumin levels which results in decreased warfarin binding so more free warfarin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
74
Q

Chronic ethanol ingestion and/or tobacco smoking with warfarin therapy can decrease INR via what mechanism?

A

Induction of warfarin metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
75
Q

Foods high in vitamin K, chewing tobacco, nutritional supplements, and/or enteral feedings with warfarin therapy can decrease INR via what mechanism?

A

Increased synthesis of clotting factors, increase vitamin K intake, decreased bioavailability of warfarin as it can bind to feeding tubes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
76
Q

What are the two main drug CLASSES that interact with warfarin?

A
  1. CYP2C9/3A4/1A2/2C19 inhibitors (may increase INR and bleeding risk)
  2. CYP2C9/3A4/1A2/2C19 inducers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
77
Q

Do NSAIDs and aspirin interact with warfarin?

A

Yes!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
78
Q

What is the FAB-Five for drugs that inhibit the metabolism of warfarin?

A

This is the way to memorize the top drug interactions with warfarin:

F- Fluconazole (Diflucan)/ Antifungals
A- Amiodarone (Cordarone)
B- Bactrim (TMP-SMX)
F- Flagyl (Metronidazole)
F- Fluoroquinolones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
79
Q

Why do fluoroquinolones (antibiotic class) lead to a massive increase in INR while on warfarin?

A

These antibiotics kill of the good gut bacteria that produce vitamin K. Without any vitamin K and the addition of warfarin, the INR increases rapidly which increases the risk for bleeding.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
80
Q

Fluconazole (Diflucan) inhibits what 3 CYP enzymes?

A

CYP2C9, 3A4, and 2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
81
Q

Amiodarone (Cordarone/Pacerone) inhibit what 2 CYP enzymes?

A

CYP2C9 and 3A4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
82
Q

Bactrim (TMP-SMX) inhibits which CYP enzyme?

A

CYP2C9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
83
Q

Flagyl (metronidazole) inhibits which CYP enzyme?

A

CYP2C9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
84
Q

The class of fluoroquinolone antibiotics inhibit which CYP enzyme?

A

Their drug interaction with warfarin is not CYP mediated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
85
Q

What 5 medications interact with Warfarin by inducing their metabolism?

A

Carbamazepine
Phenytoin
Phenobarbital
Primidone
Rifampin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
86
Q

Carbamazepine induce which 2 CYP enzymes?

A

CYP3A4 and 1A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
87
Q

Phenobarbital induces which 3 CYP enzymes?

A

CYP2C9, 3A4, and 1A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
88
Q

Primidone induces what 3 CYP enzymes?

A

CYP2C9, 3A4, and 1A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
89
Q

Phenytoin induces which 2 CYP enzymes?

A

CYP3A4 and 1A2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
90
Q

Rifampin induces which CYP enzymes?

A

CYP2C9, 3A4, 1A2, and 2C19

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
91
Q

What are the herbal supplements that can increase the effects of warfarin?

A

Cranberry, tumeric and the 3Gs being garlic, ginkgo, and ginseng

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
92
Q

What are the herbal supplements that can decrease the effects of warfarin?

A

St. John’s wort, CQ10, and green tea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
93
Q

T or F: Educating the patient on the color of their warfarin medication and how it is related to their dose is not important.

A

False. Patient need to know what dose they are on and it correlated color.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
94
Q

T or F: Patients on warfarin should be educated on the signs and symptoms of bleeding and thromboembolism.

A

True! These are the big warnings associated with warfarin use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
95
Q

What are direct oral anticoagulants?

A

These are oral anticoagulants that are not warfarin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
96
Q

What is the MOA for the direct oral anticoagulant named Dabigatran (Pradaxa)?

A

It is a prodrug that once activated is a direct thrombin inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
97
Q

T or F: Dabigatran is not a prodrug.

A

False. Dabigatran is a prodrug that is rapidly hydrolyzed to its active form in the liver and plasma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
98
Q

What is the brand name for Dabigatran?

A

Pradaxa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
99
Q

Does Dabigatran require renal dose adjustments?

A

Yes! Around 80% is excreted renally

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
100
Q

What is the average bioavailability of Dabigatran?

A

3-7%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
101
Q

When is the peak concentration of Dabigatran reached?

A

1-2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
102
Q

Is Dabigatran dialyzable?

A

Yes, this means that it can be eliminated via dialysis which may be beneficial in an overdose.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
103
Q

What is the half-life of Dabigatran?

A

12-17 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
104
Q

What is the dosing for Dabigatran in the case of prophylaxis for VTE (Venous Thromboembolism) following a total hip replacement?

A

110 mg orally for the first day about 1-4 hours after surgery followed by 220 mg once daily.

Avoid if CrCl is less than 30 ml/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
105
Q

What is the dosing for Dabigatran in the case of treatment for a deep vein thrombosis (DVT) or a pulmonary embolism (PE)?

A

CrCl greater than 30? After 5-10 days of parenteral anticoagulation give 150 mg PO BID

(Avoid if CrCl is less than 30 ml/min)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
106
Q

What ages in the pediatric population can use Dabigatran?

A

8-18 years old. They use weight based dosing in this population.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
107
Q

What are the two common adverse effects associated with Dabigatran use?

A

Bleeding and dyspepsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
108
Q

What is the antidote for Dabigatran overdose?

A

Idarucizumab (Praxbind)

It is a monoclonal antibody fragment that rapidly bind Dabigatran

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
109
Q

What are the two black box warnings associated with Dabigatran use?

A
  1. Premature discontinuation can increase risk for clotting events
  2. Spinal/epidural hematoma risk while on this medication. Could lead to bleeding in that area eventually causing paralysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
110
Q

What is unique about the drug interactions with Dabigatran?

A

The interactions are specific to the clinical indications for use so they vary from case to case.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
111
Q

When using Dabigatran during atrial fibrillation, what are the two instances of drug interactions?

A
  1. If using a p-glycoprotein inhibitor and patient has CrCl between 30-50, reduce the dose of Dabigatran or avoid it
  2. If using a p-glycoprotein inhibitor and patient has CrCl between 15-30, avoid Dabigatran
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
112
Q

When using Dabigatran during DVT/PE, what is the one instance of drug interactions?

A

If using a p-glycoprotein inhibitor and the patient has a CrCl less than 50, avoid dabigatran.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
113
Q

What are the two p-glycoprotein inducers that interact with Dabigatran and concurrent use should be avoided?

A

Rifampin and St. John’s Wort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
114
Q

What other medications should be absolutely avoided with Dabigatran use?

A

Anticoagulants, antiplatelets, and NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
115
Q

T or F: Dabigatran should be taken with a full glass of water and can be taken with food if dyspepsia is occuring.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
116
Q

What are the 3 medications that are direct oral anticoagulants but work by inhibiting factor Xa in the coagulation cascade?

A

Rivaroxaban (Xarelto)
Apixaban (Eliquis)
Edoxaban (Savaysa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
117
Q

What is the brand name for Rivaroxaban?

A

Xarelto

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
118
Q

What is the brand name for Apixaban?

A

Eliquis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
119
Q

What is the brand name for Edoxaban?

A

Savaysa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
120
Q

Do the oral Xa inhibitors require renal dosing adjustments?

A

Yes!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
121
Q

What is the bioavailability for Rivaroxaban and Apixaban?

A

Rivaroxaban is 80-100% while Apixaban is 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
122
Q

When do Rivaroxaban and Apixaban reach maximum concentrations in the body?

A

2-4 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
123
Q

Are Rivaroxaban and Apixaban highly protein bound?

A

Yes! Around 87% and higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
124
Q

What is unique about the dosing for Rivaroxaban related to its half-life being 5-9 hours?

A

Rivaroxaban is only dosed once per day even though it has a moderately small half life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
125
Q

What is unique about the dosing for Apixaban related to its half-life being 12 hours?

A

Apixaban is dosed BID even though it has a longer half-life compared to Rivaroxaban which is only dosed once per day.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
126
Q

Rivaroxaban and Apixaban are metabolized by ________ enzymes while Edoxaban is mainly a substrate for ______________.

A

CYP (3A4)
P-glycoprotein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
127
Q

What are the only two indications for Edoxaban use?

A

Stroke prevention in atrial fibrillation and treatment of VTE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
128
Q

What are the 5 indications for Apixaban use?

A
  1. Stroke prevention in atrial fibrillation
  2. DVT prophylaxis in hip and knee replacements
  3. Treatment of VTE
  4. Prevention of recurrence of VTE
  5. Heparin induced thrombocytopenia (off-label)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
129
Q

T or F: Rivaroxaban is approved for use in the pediatric population.

A

True!!!!!!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
130
Q

What is the dosing for Rivaroxaban for someone getting treated for VTE prophylaxis for total hip/knee replacement or prophylaxis of VTE in acutely ill medical patients?

A

10 mg PO daily

Avoid if CrCl less than 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
131
Q

What is Rivaroxaban dosing for the treatment of VTE, to reduce to risk of recurrence of VTE, and off-label use for heparin induced thrombocytopenia?

A

15 mg PO BID WF for 21 days for acute DVT/PE followed by 20 mg PO once daily WF

Avoid if CrCl less than 30

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
132
Q

What is the dosing for Rivaroxaban to reduce the risk of recurrence of DVT and PE?

A

After 6 months of standard anticoagulant treatment in patients with continued risk:
10 mg PO daily with out without food

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
133
Q

T or F: If a patient has a creatinine clearance less than 95 ml/min, we do not use Edoxaban.

A

False. We do not use Edoxaban if CrCl is GREATER than 95!!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
134
Q

What are the black box warnings associated with oral factor Xa inhibitors like Rivaroxaban, Apixaban, and Edoxaban?

A
  1. Premature discontinuation can increase the risk for clotting
  2. Spinal/epidural hematoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
135
Q

What are the adverse effects associated with oral factor Xa inhibitors like Rivaroxaban, Apixaban, and Edoxaban?

A

Bleeding

(Abnormal LFTs for Edoxaban as well)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
136
Q

What is the antidote for Rivaroxaban and Apixaban?

A

Andexanet alfa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
137
Q

What are the 6 warnings/precautions associated with factor Xa inhibitor use?

A

Bleeding risk, antiphospholipid syndrome (triple +), hepatic + renal impairment, GI diseases/bariatric surgery, prosthetic heart valves (DOACs are not used for mechanical valves)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
138
Q

If a person is taking a p-glycoprotein inhibitor and a strong CYP3A4 inhibitor, Rivaroxaban should be _______________

A

Avoided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
139
Q

Rivaroxaban should never be taken with ____________, _______________, and ___________.

A

Anticoagulants, antiplatelets, and NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
140
Q

If a person is taking a p-glycoprotein inducer and a strong CYP3A4 inducers, Rivaroxaban should be _______________

A

Avoided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
141
Q

If a person is taking a p-glycoprotein inhibitor and a weak/moderate CYP3A4 inhibitor in patients with CrCl between 15-80 mL/min, Rivaroxaban should be _______________

A

Avoided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
142
Q

If a person is taking a p-glycoprotein inducer and a strong CYP3A4 inducer, Apixaban should be _______________

A

Avoided

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
143
Q

If a person is taking a p-glycoprotein inhibitor and a strong CYP3A4 inhibitor, Apixaban should be _______________

A

Avoided or dose adjusted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
144
Q

Apixaban should never be taken with ____________, _______________, and ___________.

A

Anticoagulants, antiplatelets, and NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
145
Q

T or F: Edoxaban use should be avoided in patients taking p-glycoprotein inducers (rifampin) and inhibitors.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
146
Q

Edoxaban should never be taken with ____________, _______________, and ___________.

A

Anticoagulants, antiplatelets, and NSAIDs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
147
Q

What is the Apixaban dosing for prophylaxis of DVT following total knee/hip replacement?

A

2.5 mg PO BID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
148
Q

What is the Apixaban dosing for the treatment of DVT or PE and possible off-label use of HIT?

A
  1. 10 mg PO BID for 7 days
  2. 5 mg PO BID after that
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
149
Q

What is the Apixaban dosing for the reduction of risk of recurrence of DVT/PE following initial therapy?

A

2.5 mg PO BID after initial 6 months of treatment for DVT/PE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
150
Q

T or F: Food does not enhance the bioavailability of Rivaroxaban.

A

False. Food does enhance the bioavailability of rivaroxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
151
Q

What two medications need parenteral bridging for the treatment for DVT/PEs before taking the actual oral anticoagulation medication?

A

Dagibatran and Edoxaban

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
152
Q

T or F: If the blood vessel is intact, platelet activation/ coagulation does not occur.

A

True!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
153
Q

Efficacy of antithrombin (a natural anticoagulant) has 1000x enhanced efficacy when ____________ sulfate proteoglycans are administered.

A

Heparan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
154
Q

The activation of Protein C&S (natural anticoagulant) is dependent on _______ binding to Gla residues.

A

Calcium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
155
Q

What are the 3 heparin derivatives?

A
  1. Unfractionated heparin (this is like THE heparin)
  2. Low molecular weight heparin (LMWH)
  3. Synthetic polysaccharide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
156
Q

Unfractionated heparin is a heterozygous mixture of sulfated ________________.

A

Mucopolysaccharides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
157
Q

What is the average molecular weight of unfractionated heparin?

A

5,000-30,000 daltons (very big)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
158
Q

T or F: Unfractionated heparin is commonly extracted from horse intestinal mucosa.

A

False. It is commonly extracted from porcine (pig) intestinal mucosa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
159
Q

In order for unfractionated heparin to work it must bind to ___________.

A

Antithrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
160
Q

What is the MOA of unfractionated heparin?

A

Its pentasaccharide has to bind to antithrombin and makes a conformational change and then together they deactivate factor Xa. If the polysaccharide is greater than 18 saccharides it can also inactivate factor IIa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
161
Q

What is the main difference between unfractionated heparin and low-molecular weight heparin?

A

LMWH cannot inactivate factor IIa while unfractionated heparin can inactivate factor Xa and IIa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
162
Q

What is the onset of action for unfractionated heparin?

A

Immediate when given IV and around 30 minutes when given SubQ

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
163
Q

T or F: There are renal adjustments for unfractionated heparin.

A

False. There are no renal adjustments for unfractionated heparin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
164
Q

What are some blood tests that should be run to assess coagulation and monitoring while someone is on unfractionated heparin?

A

Baseline CBC, aPTT (hPTT)- activated partial thromboplastin time, and anti-Xa levels, signs and symptoms of disease progression, and adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
165
Q

What are the 6 adverse effects associated with unfractionated heparin?

A

Bleeding
Osteoporosis
Dermatological rxns
Alopecia
Hyperkalemia
Hypersensitivity

BODAHH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
166
Q

What is heparin-induced thrombocytopenia (HIT)?

A

This is a platelet count that has decreased 50% or more from baseline (less than 150 x 10^9) and/or thrombosis that occurs between days 5 and 14 following initiation of heparin.

This is a low platelet count that can be associated with immunity or can be non-immune. Non-immune mediated is more common than immune mediated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
167
Q

If someone has immune HIT following heparin, how do we manage this?

A

Immune HIT has a delayed onset of action (4-14 days) as the body has to make antibodies for the heparin. We manage it by stopping the heparin, then giving parenteral direct thrombin inhibitors like Argatroban or Bivalirudin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
168
Q

In HIT treatment, warfarin should not be given until platelets are above __________.

A

150,000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
169
Q

If someone has non-immune HIT following heparin, how do we manage this?

A

Non-immune HIT onset is less than 4 days and we manage this via observation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
170
Q

What are the 6 indications for the use of heparin?

A
  1. TX for DVT, PE, peripheral arterial embolism, and acute coronary syndrome
  2. Prophylaxis for DVT
  3. A. fib with embolization
  4. Disseminated intravascular coagulation (DIC)
  5. Bridging to/from other anticoagulant (typically warfarin)
  6. Prevention of clotting during procedures
171
Q

What are the 3 specific contraindications for unfractionated heparin?

A
  1. Prior HIT
  2. Hypersensitivity
  3. Active bleeding
172
Q

Coagulation monitoring via aPTT while on unfractionated heparin is crucial. How often should aPTT be monitored?

A

At first, monitor every 6 hours for 24 hours and then daily if aPTT is in range. Monitor every 6 hours after a dose change of unfractionated heparin.

173
Q

What is the dosing for unfractionated heparin for prophylaxis for VTE?

A

5,000 Units SubQ BID/TID (BID dosing used for super ill old people)

174
Q

T or F: Anticoagulants do not burst clots, they keep clots from forming.

175
Q

What is the dosing for unfractionated heparin for the treatment of VTE?

A

IV bolus of 80 units/kg followed by a continuous IV infusion of 18 units/kg/hr. Titrate based on aPTT

176
Q

What is the dosing for unfractionated heparin from the treatment of acute coronary syndrome?

A

IV bolus of 60 Units/kg followed by continuous IV infusion 12-14 Units/kg/hr. Titrate based on aPTT.

177
Q

What is the protocol for reversing an overdose on unfractionated heparin?

A
  1. Stop the heparin (check aPTT 1 hour after holding)
  2. Protamine sulfate administration to neutralize the heparin
  3. Whole blood transfusion if serious bleeding
178
Q

What are the two available forms of low-molecular weight heparin?

A

Dalteparin (Fragmin) and Enoxaparin (Lovenox)

179
Q

T or F: Low-molecular weight heparin has greater inhibition of factor Xa due to its shorter chain not allowing for factor IIa inhibition.

A

True! Its average weight is 5,000 daltons

180
Q

What is the MOA of low-molecular weighted heparin?

A

Its smaller polysaccharide chain that with antithrombin binds and inhibits factor Xa.

181
Q

IV enoxaparin (Lovenox) is indicated for _______ and _________ only.

A

STEMI and Percutaneous coronary intervention (PCI)

182
Q

What is the onset of action for Enoxaparin (Lovenox)?

A

3-5 hours for the maximum effect

183
Q

Enoxaparin (Lovenox) renal dosing is required for a CrCl less than __________ ml/min.

184
Q

T or F: Enoxaparin (Lovenox) is okay to give in those with acute renal dysfunction.

A

False! Do not give!

185
Q

Does LMWH heparin or unfractionated heparin have a greater risk for HIT?

A

Unfractionated heparin has a greater risk of HIT due to it being a larger molecule.

186
Q

Heparin dosing uses ________ based dosing and ________ needs to be monitored while on this medication.

A

Weight
aPTT

187
Q

LMWH heparin dosing uses fixed dosing for prophylaxis but uses weight based dosing for _________________. _______ needs to be monitored while on this medication.

A

Therapeutic treatment
Anti-Xa

188
Q

How often does anti-Xa need to be monitored while on low-molecular weighted heparin?

A

Draw 4-6 hours after dose

189
Q

What are the 3 indications for use for Dalteparin?

A
  1. DVT prophylaxis
  2. TX for VTE in cancer patients
  3. Prophylaxis of ischemic complications following acute coronary syndrome
190
Q

What are the 4 indications for use for Enoxaparin?

A
  1. DVT prophylaxis
  2. Inpatient/outpatient treatment for acute VTE
  3. Prophylaxis for ischemic complications of unstable angina and MI
  4. TX for STEMI
191
Q

What are the 4 adverse effects associated with low-molecular weighted heparins?

A

Bleeding, hypersensitivity, HIT, and osteoporosis

192
Q

What are the 3 contraindications for low-molecular weighted heparin?

A

Active bleeding, past HIT, and hypersensitivity

193
Q

What is the black box warning associated with the use of low-molecular weighted heparin?

A

Epidural/spinal puncture hematoma resulting in paralysis.

194
Q

T or F: Low molecular weight heparin can absolutely not be used during pregnancy.

A

False!!!! LMWH heparin is actually the drug of choice for anticoagulation during pregnancy for the treatment and prophylaxis of DVT.

195
Q

What is something that should be monitored when giving LMWH heparin to pregnant people?

A

Monitor anti-Xa due to the changing volume of distribution during pregnancy.

Also monitor CBC, SCr, aPTT, PT, and signs and symptoms of bleeding

196
Q

What is the dosing for the LMWH called Enoxaparin (Lovenox) in cases of acute treatment for VTE?

A

1 mg/kg SubQ Q12H

OR

1.5 mg/kg SubQ Q24H

Cap dose at 150 mg or monitor anti-Xa more

197
Q

What is the dosing for LMWH called Enoxaparin (Lovenox) in the cases of prophylaxis for VTE?

A

30 mg SubQ BID or 40 mg SubQ daily

(For obese patients: 40 mg SubQ BID or 0.5 mg/kg SubQ BID)

198
Q

T or F: Enoxaparin has no renal adjustments to dosing for a CrCl less than 30 ml/min.

A

False. Enoxaparin absolutely needs dose adjustments for CrCl less than 30 ml/min

199
Q

What is the renal adjustment dosing for a CrCl less than 30 for Enoxaparin for DVT prophylaxis?

A

30 mg SubQ once daily

200
Q

What is the renal adjustment dosing for a CrCl less than 30 for Enoxaparin for VTE treatment?

A

1 mg/kg SubQ once daily

201
Q

T or F: Enoxaparin is fine to use in those on dialysis.

A

FALSE. Do not use in those on dialysis

202
Q

What is the protocol if someone were to overdose on LMWH heparin?

A
  1. Stop the LMWH
  2. Monitor for signs and symptoms of bleeding
  3. Transfuse PRN for major bleeding
  4. Protamine may partially neutralize the LMWH
203
Q

What is the only synthetic pentaccarhide that is FDa approved for us?

A

Fondaparinux (Arixtra)

204
Q

What is the brand name for the synthetic pentaccarhide, Fondaparinux?

205
Q

What is the MOA for the synthetic pentaccarhide like Fondaparinux?

A

It binds to antithrombin and exclusively binds and deactivates factor Xa (not IIa as it is much too small to do that).

206
Q

When is the peak concentration of Fondaparinux reached?

A

2-3 hours with 20ish hour half life

207
Q

Fondaparinux is contraindicated for use if CrCl is less than _________ or the patient is on __________.

A

30 ml/min
Dialysis (ESRD)

208
Q

What should be monitored while on Fondaparinux?

A

Anti-Xa levels (can be considered as machiene would need to be calibrated for this medication)

209
Q

What are the main indications for use of Fondaparinux?

A

DVT and PE treatment and VTE prophylaxis

210
Q

What are the two adverse effects associated with Fondaparinux?

A

Bleeding and thrombocytopenia (low platelets)

211
Q

What is the black box warning associated with Fondaparinux?

A

Epidural/spinal puncture risk for hematoma

212
Q

What are the 5 contraindications for Fondaparinux use?

A
  • allergy to medication
  • CrCl less than 30
  • body weight less than 50kg (can’t use for prophylaxis)
  • major active bleeding
  • bacterial endocarditis
213
Q

What should be monitored when a patient is on Fondaparinux?

A

CBC, aPTT, PT, signs and symptoms of bleeding

214
Q

What is the dosing for Fondaparinux in VTE and HIT Treatment?

A

-less than 50 kg: 5 mg SubQ daily
- 50-100kg: 7.5 mg SubQ daily
- Greater than 100kg: 10 mg SubQ daily

215
Q

What is the dosing for Fondaparinux in VTE prophylaxis?

A

2.5 mg SubQ daily and avoid if under 50 kg

216
Q

What are the two direct thrombin inhibitors we need to know?

A

Argatroban (Acova) and Bivalirudin (Angiomax)

217
Q

What is the brand name for the direct thrombin inhibitor Argatroban?

218
Q

What is the brand name for the direct thrombin inhibitor Bivalirudin?

219
Q

T or F: Direct thrombin inhibitors have very long half lifes.

A

False. They have very short half lives being 30-60 minutes

220
Q

What are the two types of VTE?

A

DVT and PE

221
Q

Why are hospitalized patients at risk for VTE?

A

They are typically immobile, have indwelling catheters, or are recovering from trauma.

222
Q

Which surgery has the highest absolute risk for DVT?

A

Spinal cord surgery (60-80%)

223
Q

When at the hospital should medications be given to prevent DVTs?

A

Basically all surgeries, major trauma, acutely ill and high risk patients, cancer patients, COVID-19 patients, and critically ill patients

224
Q

What are some good non-pharmacological practices for VTE prevention?

A

Walking, graduated compression stockings, intermittent pneumatic compression, and venous foot pumps

225
Q

What scoring system is used to assess risk for VTE in surgical patients?

A

Caprini score

226
Q

What scoring system is used to assess risk for VTE in hospitalized patients?

A

Padua score

227
Q

Per the CHEST 2016 guidelines on DVT prophylaxis, what should medical patients be given?

A

LMWH, unfractionated heparin, fondaparinux, or rivaroxaban

228
Q

Per the CHEST 2016 guidelines on DVT prophylaxis, what should critically ill medical patients be given?

A

LMWH like Enoxaparin or unfractionated heparin

229
Q

Per the CHEST 2016 guidelines on DVT prophylaxis, what should outpatient cancer patients with additional risk and solid tumors be receiving?

A

LMWH like Enoxaparin or unfractionated heparin

230
Q

What are the additional risk factors in cancer patients that advise administering prophylactic medication for DVT?

A

Prior VTE, immobilization, hormone treatment, angiogenesis inhibitors, thalidomide or lenalidomide use.

231
Q

What is the dosing for Enoxaparin in DVT prophylaxis use?

A

40 mg SubQ daily

(CrCl less than 30, do 30 mg SubQ daily)

232
Q

Per the CHEST 2016 guidelines on DVT prophylaxis, what should someone at high bleeding risk or actively bleeding recieve?

A

Nothing!! Only use mechanical prophylaxis for these patients as you do not want them to bleed more.

233
Q

T or F: Rivaroxaban can be used in DVT prophylaxis for hip fracture surgery.

A

False. Do not use rivaroxaban for hip fracture surgery in DVT prophylaxis.

234
Q

Per the CHEST 2016 guidelines on DVT prophylaxis, what is the preferred DVT prophylaxis medication for those undergoing hip/hip fracture/knee surgery?

A

LMWH like enoxaparin. Can also use fondaparinux or dabigatran

235
Q

What is the dosing for Fondaparinux (Arixtra) in DVT prophylaxis?

A

2.5 mg SubQ daily

236
Q

At what weight can Fondaparinux no longer be used?

A

Less than 50kg

237
Q

What is the dosing for dabigatran in DVT prophylaxis?

A

220 mg PO daily

238
Q

For patients undergoing major orthopedic surgery (not knee/hip/etc), how long should VTE prophylaxis be?

A

Up to 35 days

239
Q

What are the main differences between LMWH and unfractionated heparin?

A

LMWH is slightly more effective, has a longer half-life, and more expensive. Unfractionated heparin is reversible, less expensive, and preferred in end-stage renal disease. Both have similar bleeding risks.

240
Q

What are the main differences between LMWH and Fondaparinux (synthetic pentasaccharide parenteral anticoagulant)?

A

Fondaparinux is more effective and only FDA indicated drug for hip fracture surgery, it is safe for HIT but it can’t be used in those below 50 kg and in those with CrCl less than 30.

241
Q

How is LMWH monitored in prophylaxis patients?

A

Draw blood 4 hours after 3-4th dose and aim for peak goal of medication at 0.2-0.5 IU/mL. No need to monitor anti-Xa in most patients.

242
Q

What is the guideline for VTE prophylaxis in covid-19 patients?

A

LMWH then unfrationated heparin

243
Q

What is the clinical presentation of a DVT?

A

Skin discoloration or darkening, increased leg circumference, palpable cord, Homan’s sign (discomfort behind knee with foot dorsiflexion), and obviously pain, swelling, and warmth

244
Q

What are the signs and symptoms of a PE?

A

Cough, chest pain, SOB, spitting up blood, palpitations, dizziness, tachycardia, tachypnea, rales lung sounds, sweaty, cyanotic, hypotensive

245
Q

What is a saddle PE?

A

This is when the blood is stuck in the trachea before it splits into the two lungs

246
Q

What are the other locations for PEs?

A

Lobar, segmental, and subsegmental

247
Q

What are the 3 classifications for PE in terms of hemodynamic compromise?

A

Massive, submassive, and low-risk

248
Q

What is categorized as a massive PE?

A

Sustained hypotension with systolic below 90 for 15+ minutes, pulselessness, or persistent profound bradycardia. If the pulmonary tree is blocked over 50%, or there is a high risk of mortality.

249
Q

What is categorized as a submassive PE?

A

Hemodynamically steady (no hypotension) but often accompanied by right ventricle dysfnction.

250
Q

What is categorized as a low-risk PE?

A

No right ventricular dysfunction present and a low risk of death.

251
Q

What is D-dimer testing?

A

This is a test used that can rule out a DVT or PE

252
Q

If someone is suspected of experiencing a VTE, what lab tests should be run to rule out a heart attack?

A

Cardiac troponins, B-natriuretic peptide, and D-dimer testing

253
Q

What are the different VTEs we treat with anticoagulation?

A

Proximal DVT, PE, acute isolated distal DVT (with severe symptoms and high risk for clot extension), subsegmental PE (with high risk of recurrent VTE), incidental asymptomatic PE, cerebral vein/venous sinus thrombosis, and a superficial venous thrombosis.

254
Q

What are the different VTEs that we do not treat with anticoagulation but solely monitor them?

A

Acute isolated distal DVT (without severe symptoms and low risk for extension) and subsegmental PE with low risk of recurrent VTE

255
Q

If someone is a contraindication for the use of anticoagulation therapy, what device can be placed instead?

A

Inferior vena cava filter. It stops a clot from entering the lungs by catching it in the heart during movement.

256
Q

What is the treatment for someone diagnosed with an extensive iliofemoral DVT or a massive/submassive PE?

A
  1. Thrombolytic/fibrinolytic like tenecteplase
  2. IV unfractioned heparin
257
Q

What is the treatment dosing for unfractionated heparin?

A

IV bolus at 80 Units/Kg followed by continuous infusion at 18 Units/kg/hour. Titrate based on aptt.

258
Q

What are the contraindications for the use of thrombolytics/fibrolytics?

A
  • History of intracranial hemorrhage
  • Structural intracranial cerebrovascular disease
  • Intracranial malignancy
  • active bleeding
  • recent spinal canal or brain stroke surgery in last 3 months
  • recent head trauma
259
Q

If a hemodynamically unstable patient is contraindicated for thrombolytic/fibrinolytic use, what is done instead?

A

Thrombectomy/ embolectomy.

260
Q

What is the dosing for the thrombolytic/fibrinolytic Tenecteplase for the treatment of an extensive iliofemoral DVT or massive/submassive PE?

A

30-50 mg bolus over 5-10 seconds (adjusted for BW, do not need to know the individual BW doses)

261
Q

If someone is not have an extensive iliofemoral DVT or a massive/submassive PE but still experiencing some sort of PE or DVT, what are the treatment options?

A

There are 3 treatment options if a patient does not fall into the other category:

  1. Apixaban or Rivaroxaban
  2. Parenteral anticoagulation for 5-10 days bridged to dabigatran or edoxaban
  3. IV unfractionated heparin or LMWH or fondaparinux bridged to warfarin
262
Q

What is the treatment dosing for rivaroxaban?

A

15 mg PO BID for 21 days then 20 mg once daily with food

263
Q

What is the treatment dosing for apixaban?

A

10 mg PO BID for 7 days then 5 mg BID

264
Q

What is the treatment dosing for fondaparinux?

A

<50 kg= 5 mg
50-100=7.5 mg
>100= 10 mg

265
Q

What is treatment dosing for dabigatran?

A

150 mg PO BID

266
Q

What is the treatment dosing for Edoxaban?

A

60 mg PO daily (after 5-10 days of parenteral anticoagulation)

(30 mg PO daily if CrCl 15-50, BW less than 60, or if p-glycoprotein inhibitors like verapamil or quinidine are present)

267
Q

When should edoxaban be avoided?

A

If CrCl is too good and above 95 CrCl

268
Q

How should parenteral agents and warfarin be bridged?

A

Parenteral agents and warfarin should overlap for 5 days with an INR of 2 or greater for 24 hours. Finally, there needs to be 2 INRs in therapeutic range 24 hours apart in order to go full warfarin.

269
Q

Expect the greatest INR increase _____-_____ hours after initiating warfarin.

A

48-72 hours

270
Q

If a person has renal disease and a CrCl less than 30, what anticoagulant is preferred?

271
Q

In pregnancy, what is the only anticoagulant we can give?

272
Q

If someone has poor adherence to anticoagulation medications, what is the preferred medication to put them on and why?

A

Warfarin because it is based on weekly dosing so they could double up if they missed a day

273
Q

What is the 1st line long-term anticoagulant preferred choice?

A

DOACs (basically all the oral ones except warfarin)

274
Q

If a person with cancer is having a VTE, what is the preferred treatment?

A

DOACs are preferred

275
Q

If a person has antiphospholipid syndrome, what anticoagulation medication is preferred?

A

Warfarin with target INR of 2.5

276
Q

At minimum, during treatment phase after a VTE, a patient should be anticoagulated for at least __________ months. There is also an extended phase of anticoagulation which has no stop date.

277
Q

T or F: DOAC dose reduction is now recommended during the extended phase of anticoagulation after a VTE.

A

True. Consider Rivaroxaban 10 mg daily and Apixaban 2.5 mg PO BID

278
Q

If a patient had a VTE that was provoked by surgery, they need to be anticoagulated for at least ________ months.

279
Q

If a patient had a VTE that was provoked by a non-surgical transient risk factor, they need to be anticoagulated for at least ________ months.

280
Q

If a patient had an isolated distal DVT of the leg, they need to be anticoagulated for at least ________ months.

281
Q

If a patient had an unprovoked VTE, they need to be anticoagulated for at least _____ months and ________ phase anticoagulation is recommended.

A

3 months
Extended phase

282
Q

If someone had an unprovoked VTE and they have low-bleeding risk, they need to be on __________ therapy with anticoagulation while someone with a high bleed risk should be good with only ________ months of anticoagulation therapy.

A

Extended
3 months

283
Q

What is the target INR goal for those on warfarin?

284
Q

Is aspirin a good treatment option for VTE?

A

It is not a reasonable alternative to extended therapy but could help prevent recurrence of VTEs.

285
Q

How is type 2 HIT categorized?

A

Immune-mediated type 2 HIT is categorized by a 50% decrease in baseline platelets and a plt nadir greater than 20.

286
Q

How is HIT treated?

A
  1. Stop heparin
  2. Anticoagulate with Direct Thrombin Inhibitor like argatroban or bivalirudin)
  3. Avoid warfarin until plts are above 150,000
287
Q

For the treatment of HIT, what is the dosing for Argatroban?

A

2 mcg/kg/min. Monitor aPTT, CBC, and body weight. aPTT goal is 1.5-3x baseline

288
Q

How is argatroban transitioned to warfarin?

A

Decrease or keep argatroban at 2mcg/kg/min and initiate usual warfarin dose (5mg). Argatroban can be stopped one INR is greater than 4. Repeat INR in 4-6 hours, if it fell you can restart the argatroban. EXPECT HIGH INRs as argatroban and warfarin together will elevate INR.

289
Q

What is the dosing for bivalirudin in the treatment of HIT?

A

0.15-0.2 mg/kg/hr

If CrCl is less than 30 start at 0.04-0/08 mg/kg/hr and if CrCl between 30-60, start at 0.08-0.12 mg/kg/hr.

290
Q

In terms of platelet aggregation, what is released in the first step in response to injury or damage to the epithelium?

A

Collagen and von Willebrand factor

291
Q

In platelet aggregation, PAR-1 and PAR-4 are activated by ____________ and go on to activate COX-1 and GpIIb/IIIa.

A

Thrombin (factor IIa)

292
Q

________ is the major product of COX-1 activation in platelet aggregation.

A

TxA2 (Thromboxane)

293
Q

_______ and ________ activate GpIIb/IIIa and COX-1 to promote platelet aggregation and secretion.

A

P2Y1 and P2Y12

294
Q

________ is an endogenous compound that is secreted by endothelial cells and inhibits platelet activation.

A

Prostacyclin

295
Q

________ and _______ that are activated during platelet aggregation by both PAR-1, PAR-4, GPVI, and P2Y1 and P2Y12 doing the platelet cross-linking.

A

GPIIb and GPIIIa

296
Q

Aspirin targets what molecule in the platelet aggregation?

A

Aspirin irreversibly inhibits COX-1 which stops the production of TxA2 therefore inhibiting platelet aggregation and vasoconstriction.

297
Q

What is unique about aspirin?

A

Aspirin irreversibly inhibits COX-1 on platelets meaning it will last for the lifetime of the platelet being around 7-10 days.

298
Q

What are common adverse effects associated with aspirin use?

A

-Upper GI events due to depletion of prostaglandin for housekeeping
-Bleeding
- hemorrhagic events
- hypersensitivity
- Reye’s syndrome

299
Q

What are the two irreversible P2Y12 inhibitors we need to know?

A

Clopidogrel (Plavix) and Prasugrel (Effient)

300
Q

What are the two reversible P2Y12 inhibitors we need to know?

A

Ticagrelor (Brilinta) and Cangrelor (Kengreal)

301
Q

The age cut-off for aspirin use is ______ years old.

302
Q

Clopidogrel (Plavix) is one of the most commonly used antiplatelet agents. This drug is a ________________ prodrug.

A

Theinopyridine

303
Q

What is the dosing for clopidogrel (Plavix)?

A

300-600 mg PO loading dose (typically given in cath lab) following by 75 mg PO daily with or without food.

304
Q

Those who are poor _________ metabolizers cannot convert clopidogrel to it active form making this drug ineffective.

305
Q

What are the common adverse effects of clopidogrel?

A

Purpura (bleeding and clotting disorder), headache, chest pain, diarrhea, rash

306
Q

What are the rare but serious adverse effects of clopidogrel?

A

TTP which is thrombotic thrombocytopenia purpura (purple rash like)

307
Q

What is the black box warning associated with clopidogrel?

A

Poor CYP2C19 metabolizers have a greater risk for CV events following ACS or PCI.

308
Q

What are the major drug interactions with clopidegrel?

A

Interacts with inhibitors of CYP2C19:
Omeprazole
Cimetidine
Esomeprazole
Fluvoxamine
Amiodarone
CCBs
Grapefruit juice

GAP CCF

309
Q

__________ is also a thienopyridine prodrug.

310
Q

What is the brand name for prasugrel?

311
Q

T or F: The onset of action for Prasugrel is dependent on the loading dose.

A

True. A 60 mg loading dose would work in less than 30 minutes

312
Q

______ and ________ enzymes convert prasugrel to its active form in the liver.

A

CYP3A4 and CYP2B6

313
Q

What is the main indication for use of prasugrel?

A

Reduce future thrombotic cardiovascular events in those with acute coronary syndrome managed with percutaneous coronary intervention (PCI).

314
Q

What is the dosing for prasugrel?

A

10 mg daily after a 60 mg loading dose

(5 mg daily is BW less than 60 kg)

315
Q

What are the 3 adverse effects associated with prasugrel?

A

Bleeding
TTP (thrombotic thrombocytopenic purpura)
Increased risk for intracranial hemorrhage

316
Q

What is the main contraindication for the use of prasugrel?

A

Prior TIA or CVA

317
Q

What is the black box warning associated with Prasugrel?

A

Bleeding risk and especially those with a history of TIA/CVA.

318
Q

What is the MOA of reversible P2Y12 inhibitors like Ticagrelor and Cangrelor?

A

They are non-competitive and reversible inhibitors of the P2Y12 receptor on platelets.

319
Q

Ticagrelor is a prodrug as well that is metabolized into its active metabolite via __________ and ________.

A

CYP3A4 and CYP3A5

320
Q

T or F: The onset of action of Ticagrelor is dose dependent.

A

True. Typically a loading dose of 180 mg is given and it works in about 30 minutes.

321
Q

What are the adverse effects associated with Ticagrelor?

A

Bleeding, dyspnea, ventricular pauses, dizziness, and nausea

322
Q

What is the black box warning associated with Ticagrelor?

A

Do not use in patients with active bleeding or those who have history of an intracranial hemorrhage.

Aspirin doses above 100 mg daily reduces the effectiveness of ticagrelor and should be avoided.

323
Q

T or F: Aspirin doses greater than 200 mg reduces the effectiveness of Ticagrelor and should therefore be avoided.

A

False. Aspirin doses greater than 100mg should be avoided with Ticagrelor.

324
Q

What are the main drug interactions with Ticagrelor?

A

Avoid with strong CYP3A4 inducers and inhibitors
40 mg dose limit with lovastatin and simvastatin
Digoxin
Aspirin over 100 mg

325
Q

T or F: There is no specific method for switching between the different P2Y12 inhibitors.

A

False. There is a chart method that is used to transition people to different medications within this class.

326
Q

Why is dual-antiplatelet therapy often given Post-MI?

A

Stents placed after MIs are highly likely to trigger platelet aggregation at that site and giving two agents hitting two different targets can help decrease that risk.

327
Q

What are the two typical combination therapies given post-MI for anti-platelet effects?

A

Thienopyridine (irreversible P2Y12 inhibitor) and aspirin

Ticagrelor and aspirin

328
Q

What is the brand name for Ticagrelor?

329
Q

What is the brand name for Cangrelor?

330
Q

What is unique about the medication Cangrelor?

A

It has an onset of action of 2 minutes and a half-life of 3-6 minutes. This allows for platelet function to be restored 1 hour after discontinution.

331
Q

What is the dosing for Cangrelor?

A

30 mcg/kg IV bolus followed by 4 mcg/kg/min IV infusion

332
Q

What is the major drug interaction with Cangrelor?

A

Administer clopidogrel and prasugrel (irreversible P2Y12 inhibitors) AFTER a cangrelor infusion is discontinued.

333
Q

What are the 4 common adverse reactions associated with cangrelor use?

A

Bleeding, dyspnea, worsening renal function, and hypersensitivty

334
Q

What is the protease-activated receptor-1 (PAR-1) antagonist we need to know?

A

Vorapaxar (Zontivity)

335
Q

What is the MOA of Vorapaxar, a PAR-1 antagonist working at the level of platelet aggregation?

A

It blocks thrombin and thrombin-receptor agonist peptide (TRAP) therefore reducing platelet aggregation.

336
Q

What is unique about the drug Vorapaxar (Zontivity)?

A

It takes a long time for it to leave the body and it lasts a long time

337
Q

What is the dosing for Vorapaxar?

A

2.08 mg PO daily

Typically used with aspirin or clopidogrel

338
Q

What are the black box warnings associated with Vorapaxar?

A

Do not use in those with a history of stroke, TIA, intracranial hemorrhage, or active bleeding. This medication can increase the risk for fatal bleeding.

339
Q

What drugs interact with Vorapaxar?

A

Strong CYP3A4 inducers and inhibitors

340
Q

What are the two GbIIb/IIIa inhibitors we need to know?

A

Tirofiban (Aggrastat) and Eptifibatide (Integrilin)

341
Q

What is the MOA of the GbIIb/IIIa inhibitors?

A

Tirofiban (Aggrastat) and Eptifibatide (Integrilin) inhibit GbIIb/IIIa on the platelets to stop cross-linkage.

342
Q

What are the adverse reactions associated with GbIIb/IIIa inhibitors?

A

Bleeding, intracranial hemorrhage, stroke, and thrombocytopenia

343
Q

What is the MOA for the medication called Dipyridamole (Persantine)?

A

This is an anti-platelet agents that is a vasodilator that inhibits platelet function by inhibiting adenosine uptake and cGMP phosphodiesterase complex.

344
Q

What are the indications for use for Dipyridamole (Persantine)?

A

Cerebrovascular ischemia with aspirin
Prosthetic heart valves with warfarin

345
Q

What is the dosing for Dipyridamole (Persantine)?

A

75-100 mg 4x day as an adjunct to usual warfarin therapy

346
Q

What is the MOA for the medication called Cilostazol (Pletal)?

A

This is an antiplatelet agents that is a phosphodiesterase III inhibitor.

347
Q

What is the dosing for Cilostazol (Pletal)?

A

It is used to treat intermittent claudication at doses of 100 mg PO BID

348
Q

What is the contraindication and black box warning for Cilostazol (Pletal)?

A

Contraindicated for patients with heart failure of any severity.

349
Q

What are the 3 fibrinolytic agents we need to know?

A

Alteplase (Activase/Cathflo)
Reteplase (Retavase)
Tenecteplase (TNKase)

350
Q

What is the natural body process of breaking down a clot?

A

Normally the endothelial cells secrete tissue plasminogen factor (t-PA) at the site of injury which binds to fibrin. This action converts plasminogen to plasmin and the plasmin dissolves and digests the fibrin.

351
Q

________ and ________ inactivate t-PA after a clot has been naturally busted.

A

PAI-1 and PAI-2

352
Q

__________ inactivates plasmin to stop digesting fibrin in a clot.

A

alpha2-antiplasmin

353
Q

Rank the 3 fibrinolytics from least to most selective.

A

Reteplase<Alteplase<Tenecteplase

354
Q

What are the absolute 4 contraindications where fibrinolytics can not be used?

A

Active internal bleeding
Suspected aortic dissection
Known intracranial neoplasm (tumor)
History of hemorrhagic cerebrovascular accident (CVA) in the last 1 year

355
Q

Factor I in the coagulation cascade is also known as __________.

A

Fibrinogen

356
Q

Factor II in the coagulation cascade is also known as __________.

A

Prothrombin

357
Q

Factor III in the coagulation cascade is also known as __________.

A

Tissue factor

358
Q

Warfarin acts on what 4 factors in the coagulation cascade?

A

Factor II (prothrombin, 60 hr half life)
Factor VII
Factor IX
Factor X

359
Q

What are the three type of thrombi?

A

White, red, and fibrin deposits in capillaries

360
Q

What is a white thrombus?

A

White thrombi are platelet rich and typically seen in high pressure high flow arteries.

361
Q

What is a red thrombus?

A

Red thrombi are mainly composed of RBCs and fibrin. They are typically seen in low pressure veins and slow flow areas.

362
Q

What is the minimum amount of time when bridging to warfarin?

A

5 days. Make sure to check INR

363
Q

How is Apixaban bridged to warfarin?

A

Start the warfarin and stop the apixaban 3 days later.

For continuous anticoagulation, stop the apixaban and start LMWH and warfarin at the time the DOAC would have been due. Stop the LMWH when INR is within therapeutic range.

364
Q

How is rivaroxaban/ apixaban bridged to warfarin?

A

Can start to warfarin and stop DOAC 3 days later

or for continuous anticoagulation

Stop the DOAC and start LMWH and the warfarin at the time the DOAC would have been due. Then stop the LMWH when INR is within therapeutic range.

365
Q

If it is just prophylaxis for VTE, how much apixaban is given?

A

2.5 mg PO BID

366
Q

How should warfarin be transitioned to a DOAC?

A

Discontinue the warfarin and start the DOAC (once INR is less than 3) at the next time that the warfarin would have been due. If INR is greater than 3, stop the warfarin and check INR daily until less than 3 and then start the DOAC.

367
Q

If someone has an active GI bleed and need to be anticoagulated, what medication can they be given?

A

NO medication. They need to stick to non-pharm options.

368
Q

Which of the following is an intrinsic anticoagulant?

A. Factor II
B. Protein S
C. Fibrin
D. Thrombin

A

B. Protein S

369
Q

What is the MOA of dabigatran?

A

Inhibits factor IIa (direct thrombin inhibitor)

370
Q

Which of the following medications does not require renal dosing?

A. Enoxaparin
B. Heparin
C. Fondaparinux
D. Dabigatran

A

B. Heparin (used in dialysis)

371
Q

If parenteral anticoagulation can not be used for someone with end-stage renal disease/ dialysis, what parenteral anticoagulant should be used?

372
Q

What would be important to monitor in a pregnant woman on LMWH like Enoxaparin?

A

Anti-Xa. Pregnancy is a condition we want to monitor with this as volume of distribution is changing.

373
Q

Which class of medications prevents platelet aggregation by serving as receptors for fibrinogen and vWF?

A. P2Y12 inhibitors
B. GP IIb/IIIa inhibitors
C. tPAs
D. PAR-1 antagonist

A

B. GP IIb/IIIa inhibitors

374
Q

Which of the following is a symptom of a DVT?

A. Bilateral leg swelling
B. Elevated INR
C. Palpable cord
D. Post-thrombotic syndrome

A

C. Palpable cord

375
Q

Select the appropriate DVT prophylaxis dosing?

A. Heparin 5000 units SubQ TID
B. Enoxaparin 10mg SubQ BID
C. Rivaroxaban 60 mg PO daily
D. Fondaparinux 20 mg PO daily

A

A. Heparin 5000 Units SubQ TID

376
Q

Which of the following can be given as a continuous IV infusion?

A. Heparin
B. Warfarin
C. Enoxaparin
D. Fondaparinux

A

A. Heparin

Enoxaparin can be given IV but it is not continuous.

377
Q

Which of the following medications requires 5-10 days of parenteral anticoagulation upon initiation?

A. Apixaban
B. Dabigatran
C. Rivaroxaban
D. Enoxaparin

A

B. Dabigatran

(TX for DVT or PE, if CrCl greater than 30, after 5-10 days of parenteral anticoagulation, begin 150 mg PO BID of dabigatran (Pradaxa).

Edoxaban is for this as well

378
Q

Which of the following is true regarding extended therapy?

A. Increase dose after second VTE
B. Do not use for second VTE
C. Consider decreasing dose during extended therapy
D. Everyone should have extended therapy

A

C. Consider decreasing dose during extended therapy

379
Q

Which of the following can be used for DVT prophylaxis when a patient has an active bleed?

A. Heparin
B. Sequential compression devices
C. Warfarin
D. IVC filter

A

B. Sequential compression devices

380
Q

Which of the following is NOT a common location for a DVT?

A. Lower extremity
B. Upper extremity
C. Pulmonary arteries
D. Hemodialysis access sites

A

C. Pulmonary arteries

381
Q

Which of the following is not a major risk factor for VTE?

A. Major surgery
B. Obesity
C. Pregnancy
D. Hypotension

A

D. Hypotension

382
Q

Which of the following type of VTE is considered provoked?

A. VTE after recent surgery
B. VTE with no identifiable cause
C. VTE in patient with Factor V Leiden
D. VTE in person with history of clots

A

A. VTE after recent surgery

383
Q

What clinical scoring system is commonly used to assess the risk of VTE in hospitalized medical patients?

A

Padua prediction score. High risk for VTE with the Padua score is 4 or higher.

384
Q

What clinical scoring system is commonly used to assess risk of VTE in surgical patients?

A

Caprini Score

0-4 means low risk
5-8 means moderate risk
9 or greater means high risk

385
Q

Which of the following can increase a patients sensitivity to warfarin?

A. Age greater than 75
B. Congestive HF
C. Malnutrition
D. All of the above

A

D. All of the above

386
Q

What is the approved antidote for Rivaroxaban and apixaban overdose?

A

Andexanet alfa

387
Q

Which of the following drugs strongly increases the effects of warfarin?

a) Fluconazole
b) Amiodarone
c) Bactrim (TMP-SMX)
d) All of the above

A

D. All of the above

388
Q

Which of the following can reduce the effectiveness of warfarin?

a) Ginkgo biloba
b) St. John’s Wort
c) Garlic
d) Cranberry

A

D. St. John’s Wort

389
Q

Which of the following DOACs require administration with food to ensure proper absorption?

a) Apixaban
b) Dabigatran
c) Rivaroxaban
d) Edoxaban

A

C. Rivaroaxaban

390
Q

Which of the following anticoagulants should not be used in patients with a mechanical heart valve?

a) Warfarin
b) Apixaban
c) Edoxaban
d) Dabigatran

A

D. Dabigatran

391
Q

A 68-year-old male with atrial fibrillation is started on warfarin. After five days of therapy, his INR is only 1.3. What is the most likely reason for this delayed response?

a) Warfarin primarily affects fibrinogen, which has a long half-life.
b) Factor II (prothrombin) has a long half-life, delaying full anticoagulation.
c) Warfarin is rapidly metabolized by CYP2C9, reducing its efficacy.
d) The patient likely has an undiagnosed vitamin K deficiency.

A

B. Factor II has a long half-life therefore delaying full anticoagulation till factor II is depleted.

392
Q

A patient on warfarin for DVT prophylaxis has an INR of 6.2 but no active bleeding. What is the most appropriate management?

a) Administer IV vitamin K and fresh frozen plasma.
b) Hold warfarin and administer 1–2.5 mg of oral vitamin K.
c) Immediately administer prothrombin complex concentrate (PCC).
d) Continue warfarin at a reduced dose and recheck INR in 24 hours.

A

B. Hold the warfarin and administer 1-2.5 mg of oral vitamin K

Note this was at CHATGPT question. After further discussion with the entity, it was decided that holding warfarin and monitoring INR would be more appropriate as the patient is not actively bleeding.

393
Q

Which of the following statements best explains why edoxaban should not be used in patients with CrCl > 95 mL/min?

a) Increased renal clearance leads to lower plasma concentrations, reducing efficacy.
b) Rapid metabolism by CYP3A4 causes subtherapeutic drug levels.
c) The drug is highly protein-bound, preventing renal elimination.
d) Edoxaban increases the risk of spontaneous bleeding in patients with high renal function.

A

A. Increased renal clearance leads to lower plasma concentrations, reducing efficacy.

394
Q

A 72-year-old patient with a history of atrial fibrillation and chronic kidney disease (CrCl = 28 mL/min) is prescribed apixaban. What dose adjustment, if any, is required?

a) Reduce the dose to 2.5 mg BID if the patient also meets weight and age criteria.
b) Increase the dose to 10 mg BID for better efficacy.
c) No adjustment is needed for this renal function.
d) Discontinue apixaban and switch to warfarin.

A

A. Reduce the dose to 2.5 mg BID if the patient also meets weight and age criteria.

395
Q

A patient with a history of HIT (heparin-induced thrombocytopenia) needs anticoagulation for DVT treatment. Which is the safest option?

a) Enoxaparin
b) Fondaparinux
c) Warfarin
d) Argatroban

A

D. Argatroban

396
Q

A 56-year-old female with a mechanical heart valve and a history of DVT is switched from warfarin to a DOAC due to INR fluctuations. What is the most appropriate recommendation?

a) Switch to apixaban, as it has a lower bleeding risk than warfarin.
b) Switch to rivaroxaban, as it has been studied in mechanical heart valves.
c) Continue warfarin, as DOACs are contraindicated in mechanical heart valves.
d) Stop anticoagulation completely if the INR is well-controlled.

A

C. Continue warfarin, as DOACs are contraindicated in mechanical heart valves

397
Q

A patient on apixaban is also taking a strong CYP3A4 and P-gp inducer. What is the most appropriate action?

a) Increase the apixaban dose to compensate for increased metabolism.
b) Continue apixaban at the same dose, monitoring renal function closely.
c) Switch to warfarin, as apixaban levels will be reduced.
d) Add an antiplatelet agent to maintain efficacy.

A

C. Switch to warfarin. APixaban and rivaroxaban should be avoided in those taking a strong p-gly and CYP3A4 inducer/inhibitor.

398
Q

Which anticoagulant is most appropriate for a patient with cancer-associated VTE?

a) Warfarin
b) Low-molecular-weight heparin (LMWH)
c) Dabigatran
d) Aspirin

399
Q

A 72-year-old male with atrial fibrillation is started on warfarin for stroke prevention. His baseline INR is 1.0. After five days on 5 mg daily, his INR is 1.6. He has stable kidney function (CrCl = 65 mL/min) and no bleeding symptoms. What is the best next step?

a) Increase warfarin to 7.5 mg daily and recheck INR in 2 days.
b) Continue warfarin 5 mg daily and recheck INR in 3–5 days.
c) Discontinue warfarin and initiate a direct oral anticoagulant.
d) Administer a loading dose of 10 mg to reach therapeutic INR more quickly.

A

B. Continue warfarin 5 mg daily and recheck INR in 3-5 days.

400
Q

A 65-year-old female with a history of DVT and chronic kidney disease (CrCl = 28 mL/min) is prescribed rivaroxaban. What is the most appropriate dosing recommendation?

a) Rivaroxaban 10 mg once daily
b) Rivaroxaban 15 mg once daily
c) Switch to warfarin due to renal dysfunction
d) No change; rivaroxaban does not require dose adjustment

A

C. Switch to warfarin due to renal dysfunction. Rivaroxaban is contraindicated in those with CrCl less than 30. Warfarin can be used but generally, apixaban is saved for those with severe renal dysfunction.

401
Q

A 50-year-old patient with a newly diagnosed DVT is started on unfractionated heparin and warfarin simultaneously. After 3 days, his INR is 2.3. What is the most appropriate next step?

a) Discontinue heparin and continue warfarin alone
b) Continue both heparin and warfarin for at least 2 more days
c) Switch to a DOAC for better long-term adherence
d) Reduce warfarin dose and maintain heparin for 5 more days

A

B. Continue heparin and warfarin for at least 2 more days. This is because warfarin requires at least 5 days of overlap with heparin to ensure full anticoagulation due to it delayed effect on factor II.

402
Q

How are DOACs bridged to parenteral anticoagulants?

A

Stop the DOAC and start the parenteral at the same time the DOAC would have been given.

403
Q

T or F: FDA‐approved prescribing information requires no dose adjustment for apixaban in patients with renal impairment alone, including patients with end‐stage renal disease and those on hemodialysis. However, to qualify for apixaban dose adjustment, one must meet at least 2 of the following characteristics; just remember your ABCs:
1.Age ≥80 years.
2.Body weight ≤60 kg.
3.Creatinine (serum) ≥1.5 mg/dL.

404
Q

Those with triple positive antiphospholipid syndrome will fail DOACs and need to be on ___________.

405
Q

What symptoms are categorized as a massive PE?

A
  1. Sustained hypotension (less than 90 systolic for 15 + minutes)
  2. Pulselessness
  3. Persistent bradycardia
406
Q

What symptoms are categorized as a submassive PE?

A
  1. Hemodynamically stable possibly with RV dysfunction
407
Q

If a submassive PE is suspected, a stat _______ for a diagnosis needs to be done as well as an _________ for possible RV dysfunction.

408
Q

In those with cancer, ________ are preferred during the treatment phase after a VTE.

409
Q

In those with cancer, specifically if they have luminal GI malignancies, __________ or ___________ should be used to decrease the risk for bleeding.

A

Apixaban
LMWH

410
Q

What is the first-line preferred medication for long-term anticoagulation?

411
Q

What is the second-line preferred medication for long-term anticoagulation?

412
Q

What is the 3rd line preferred medication for long-term anticogaultion?

A

LMWH (anti-Xa goal 0.5-1)

413
Q

The target INR for those with antiphospholipid syndrome on warfarin is ________.

414
Q

An inpatient on warfarin needs to have their INR monitored at least _________.

415
Q

A person on warfarin right after hospital discharge needs their INR checked if stable in ______-______ days. If unstable they need INR checked in 1-3 days after discharge.

416
Q

During the first month on warfarin therapy, INR needs to be checked at least ________.

417
Q

If parenteral agents must be avoided for anticoagulation, what two medications are preferred for use?

A

Rivaroxaban and apixaban

418
Q

If liver disease or coagulopathy, which anticoagulant is preferred?

A

LMWH like enoxaparin is preferred. If patient has child-pugh score of A, DOACs can be used.

419
Q

T or F: In the extended phase of anticoagulation, DOAC dose reductions are now recommended. This include making apixaban 2.5 mg PO BID and rivaroxaban 10 mg PO daily.

A

True! After the first 3 months of therapy (treatment phase), it may be appropriate to lower the DOAC dose.

420
Q

Provoked VTEs can be treated for only the treatment period (3 months). However, in what situation is extended therapy considered?

A

Unprovoked VTEs (High risk for bleeding is 3 months only but medium to low risk is extended therapy). Extended phase with DOACs is recommended.

421
Q

Those with cancer and VTE should be on __________ therapy for anticoagulation.

422
Q

T or F: Aspirin is reasonable therapy for an extended treatment period following a VTE.

A

False. Aspirin is not reasonable for this reason. Aspirin may help prevent the recurrence of VTEs.

423
Q

In order to determine if a patient is experiencing type 2 immune-mediated HIT, _________ scoring is used.

A

4T

6-8= high likelihood
4-5= intermediate
0-3= low

424
Q

What is the black box warning associated with warfarin?

A

Bleeding risk!